You can buy or sell Quanterix and other stocks, options, ETFs, and crypto commission-free!
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. Read More The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
52 Week High
52 Week Low
— per share
Expected May 7, After Hours